Literature DB >> 2200692

Do different hemodynamic effects of antihypertensive drugs translate into different safety profiles?

M Moser1.   

Abstract

Various antihypertensive drugs reduce blood pressure by different mechanisms. In some instances, adverse reactions occur because of specific hemodynamic effects. Examples include syncope with alpha-blockade or vasodilator therapy; fatigue or exercise intolerance with the reduction in cardiac output following the use of beta-adrenergic inhibitors; edema, headaches, or dizziness with the use of vasodilators such as calcium entry blockers; renal failure in patients with renal artery stenosis or renal insufficiency following the use of ACE inhibitors; and marked hyponatremia with volume depletion following the use of diuretics, especially in elderly patients. In the majority of patients, however, blood pressure lowering can be achieved without significant adverse effects. Combining small doses of different agents with different hemodynamic actions often results in good blood pressure control and minimal reactions. Examples of these include diuretics and beta-adrenergic inhibitors, diuretics and ACE inhibitors, and beta-blockers and vasodilators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200692     DOI: 10.1007/bf01409483

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  I. Critical evaluation of drug therapy of hypertension.

Authors:  M MOSER; T W MATTINGLY
Journal:  Postgrad Med       Date:  1955-05       Impact factor: 3.840

2.  Current therapeutics. 125. Phenoxybenzamine.

Authors:  M MOSER
Journal:  Practitioner       Date:  1958-05

3.  Reversible renal failure during treatment with captopril.

Authors:  P R Farrow; R Wilkinson
Journal:  Br Med J       Date:  1979-06-23

Review 4.  Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.

Authors:  M Moser
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

5.  Nitrendipine in the treatment of mild to moderate hypertension.

Authors:  M Moser
Journal:  Angiology       Date:  1988-01       Impact factor: 3.619

6.  Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity.

Authors:  R C Tarazi; H P Dustan; E D Frohlich
Journal:  Circulation       Date:  1970-04       Impact factor: 29.690

7.  Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension.

Authors:  V Papademetriou; J F Burris; A Notargiacomo; R D Fletcher; E D Freis
Journal:  Arch Intern Med       Date:  1988-06

8.  Diuretic-induced ventricular ectopic activity.

Authors:  O B Holland; J V Nixon; L Kuhnert
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

9.  Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension.

Authors:  J E Madias; N E Madias; H P Gavras
Journal:  Arch Intern Med       Date:  1984-11

10.  Historical perspective on the management of hypertension.

Authors:  M Moser
Journal:  Am J Med       Date:  1986-05-23       Impact factor: 4.965

View more
  1 in total

1.  Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.

Authors:  P Weidmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.